84 related articles for article (PubMed ID: 3429992)
21. Hormone-refractory breast cancer remains sensitive to the antitumor activity of heat shock protein 90 inhibitors.
Beliakoff J; Bagatell R; Paine-Murrieta G; Taylor CW; Lykkesfeldt AE; Whitesell L
Clin Cancer Res; 2003 Oct; 9(13):4961-71. PubMed ID: 14581371
[TBL] [Abstract][Full Text] [Related]
22. [Effects of female sex steroid hormones on human endometrial adenocarcinoma transplanted into nude mice].
Miyawaki Y
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2607-16. PubMed ID: 2614195
[TBL] [Abstract][Full Text] [Related]
23. Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen.
Langdon SP; Gabra H; Bartlett JM; Rabiaz GJ; Hawkins RA; Tesdale AL; Ritchie AA; Miller WR; Smyth JF
Clin Cancer Res; 1998 Sep; 4(9):2245-51. PubMed ID: 9748145
[TBL] [Abstract][Full Text] [Related]
24. [Experimental chemoendocrine therapy of human breast carcinoma xenograft serially transplanted into nude mice].
Watanabe O
Nihon Geka Gakkai Zasshi; 1994 Apr; 95(4):263-70. PubMed ID: 7910941
[TBL] [Abstract][Full Text] [Related]
25. Droloxifene--a novel antiestrogen in endocrine dependent human tumors xenotransplanted into nude mice.
Stelzer P; Staab HJ; Kömpf J
Strahlenther Onkol; 1989 Jul; 165(7):559-60. PubMed ID: 2749496
[No Abstract] [Full Text] [Related]
26. Tamoxifen modulates the expression of Ki67, apoptosis, and microvessel density in cervical cancer.
Ferrandina G; Ranelletti FO; Larocca LM; Maggiano N; Fruscella E; Legge F; Santeusanio G; Bombonati A; Mancuso S; Scambia G
Clin Cancer Res; 2001 Sep; 7(9):2656-61. PubMed ID: 11555576
[TBL] [Abstract][Full Text] [Related]
27. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Nutr Cancer; 2007; 58(2):162-70. PubMed ID: 17640162
[TBL] [Abstract][Full Text] [Related]
28. [Experimental and clinical study on endocrine therapy of breast carcinoma, with special reference to the nuclear estrogen receptor].
Kubouchi K
Nihon Geka Gakkai Zasshi; 1984 Nov; 85(11):1405-17. PubMed ID: 6521721
[TBL] [Abstract][Full Text] [Related]
29. Hormonal therapy of human endometrial adenocarcinoma in a nude mouse model.
Zaino RJ; Satyaswaroop PG; Mortel R
Cancer Res; 1985 Feb; 45(2):539-41. PubMed ID: 3967228
[TBL] [Abstract][Full Text] [Related]
30. Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic mice.
Schafer JM; Lee ES; O'Regan RM; Yao K; Jordan VC
Clin Cancer Res; 2000 Nov; 6(11):4373-80. PubMed ID: 11106256
[TBL] [Abstract][Full Text] [Related]
31. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
32. [Experimental chemo- and chemoendocrine therapy of human breast carcinomas serially transplanted into nude mice].
Koh J
Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):91-102. PubMed ID: 3129645
[TBL] [Abstract][Full Text] [Related]
33. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.
Coezy E; Borgna JL; Rochefort H
Cancer Res; 1982 Jan; 42(1):317-23. PubMed ID: 7053859
[TBL] [Abstract][Full Text] [Related]
34. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.
Lee TH; Chuang LY; Hung WC
Oncogene; 1999 Jul; 18(29):4269-74. PubMed ID: 10435640
[TBL] [Abstract][Full Text] [Related]
35. Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labeling and flow cytometry.
Sarkaria JN; Gibson DF; Jordan VC; Fowler JF; Lindstrom MJ; Mulcahy RT
Cancer Res; 1993 Sep; 53(18):4413-7. PubMed ID: 8364937
[TBL] [Abstract][Full Text] [Related]
36. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
37. Estradiol induced changes in tumor growth and steroid receptor content in a heterotransplanted human endometrial adenocarcinoma.
Horvath G; Fernö M; Baldetorp B; Cameron R; Ranstam J
In Vivo; 1991; 5(4):401-6. PubMed ID: 1810429
[TBL] [Abstract][Full Text] [Related]
38. Photoaffinity labeling of the progesterone receptor from human endometrial carcinoma.
Clarke CL; Satyaswaroop PG
Cancer Res; 1985 Nov; 45(11 Pt 1):5417-20. PubMed ID: 4053015
[TBL] [Abstract][Full Text] [Related]
39. [Experimental multihormone therapy on human breast carcinomas grown in nude mice].
Fukutomi T
Nihon Geka Gakkai Zasshi; 1989 Dec; 90(12):2021-30. PubMed ID: 2626154
[TBL] [Abstract][Full Text] [Related]
40. Effect of estrogen and progesterone on the growth of human ovarian dysgerminoma heterotransplanted to athymic nude mice.
Ochiai K; Isonishi S; Hirama Y; Yasuda M; Terashima Y
Asia Oceania J Obstet Gynaecol; 1991 Jun; 17(2):147-58. PubMed ID: 1867584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
